Adam ElNaggar

Dr Soliman on the Use of ctDNA as a Clinical Trial End Point in Endometrial Cancer onclive.com/view/dr-solima… via @onclive

🔥 Where were you when the *practice changing* talks on endometrial cancer were presented? 🔥 These were the scenes at #SGO2023 before/after Dr. Eskander (@rne_md) & Dr. Mirza (@MirzaCPH) took the stage. The standing ovation was after a patient with hx of advanced #EndometrialCancer thanked the study teams & everyone in the room for all the work being done to improve patients’ lives. There was so much buzz surrounded these results (as you can tell by the conference choice of music 😉) & it was truly incredible to be there in person! #SGOmtg #PatientsPurposeProgress #gyncsm #gyncancer #Oncoalert #oncology #MedTwitter #MedEd @SGO_org @StephanieVBlank @AngelesSecord @amandanfader @seoultrainmd @JennyMueller_ @leitaomd @pedroramirezMD @IJGConline @IJGCfellows @agz_eriksson @BjerreTrent @RyanKahnMD1 @onco_punch @ArendRebecca @gynoncjnls @UWashOBGYN @TeamEndo_MSK @OncLive @LatinxOncology @LatinoSurgery

New standard of care for advanced/metastatic endometrial cancer. Congratulations to Dr. Ramez Eskander and Dr. Mansour Mirza. HR 0.3! Amazing. #SGOmtg

🧬🤔 What’s the latest on circulating tumor DNA in #GynCancer? Watch as Dr. Adam ElNaggar (@onco_punch/@NateraOncology) and @PamSolimanMD (@MDAndersonNews) discuss their work in this rapidly evolving space. There was standing room only at this #SGO2023 focused session! #SGOMtg #gyncsm #gynoncology #onctwitter #medtwitter #ctDNA #liquidbiopsy @SGO_org @AngelesSecord @amandanfader @SwisherLiz @NateraWomen @NateraGenetics @LatinxOncology @LatinoSurgery @UWashOBGYN @UWMedicine @seoultrainmd @leitaomd @pedroramirezMD @TeamEndo_MSK @gynoncjnls @IJGConline @BjerreTrent @agz_eriksson @BarbNorquist @OncLive

TAKE ACTION – Ask Your Member to Sign the Fitzpatrick-Meng-Torres Dear Colleague in Support of the OCRP votervoice.net/Shares/BAAAAAS…

Arnab Basu and ctDNA positivity in renal cancer in renal cancer . 70% +ve in M1 disease is higher than we expected. Tracking patients is feasible #GU23

⚡️Some renal cell cancer patients that receive adjuvant Pembro based on KEYNOTE-564 may ALREADY be CURED but are OVER treated w/risk of developing toxicity. Is there a role for MRD to find these patients? Dr. Arnab Basu answers this❓at @ASCO #GU23 👇 vumedi.com/video/asco-gu-…

#ICYMI: Medicare Green Lights Coverage of #Signatera MRD Test for #BreastCancer. Read more via @Inside_PM ow.ly/hVjN50MYIAv

Medicare Extends Coverage of Natera’s Signatera™ MRD Test to Breast Cancer natera.com/company/news/m…

Natera Awarded National MRD Testing Contract by the U.S. Department of Veterans Affairs natera.com/company/news/n…

New Publication Validates Performance of Natera's Signatera™ MRD Test in Ovarian Cancer prn.to/3zjytRy

Natera Listed as One of World’s Most Innovative Health Companies by Fast Company natera.com/company/news/n…